The people affected help design the study.
Elevate Impact is the research partner and a module of the stack, live in production with the sickle cell community. Design lives on the platform. Execution does not. The public record is on the site and on LinkedIn. Connecting it to AMP, NEOS, AZOA, and Fractal Engine is in build, which is a different sentence from “connected.”
From a question to a study design people trust
It does not run clinical trials or replace research teams. It prepares the work so the team can build the evidence.
Brings people in
Makes knowledge usable
Prepares the research
Keeps the learning
Four modules on one substrate
Discussion & Collaboration
Where patients, clinicians, advocates and researchers shape the question together.
Learning & Development
Courses and lessons that make clinical and research knowledge usable by the people it affects.
AI & Data
Turns questions into finished, expert-checked study designs. AI assists; it does not approve research.
Analytics, Compliance & Process
A 6-stage lifecycle with 5 gates, a consent register and an audit trail.
Six stages, five gates
Every study moves through a 6-stage lifecycle with 5 gates. A consent register and an audit trail record who agreed to what, and when. Experts review; AI does not approve.
In production with the sickle cell community
Platform figures, September 2026. Minority Business Enterprise certified.
In the lab: PrimusNeo brings the team and technology together. Elevate Impact helps the team build the evidence.
How it connects to the stack
Integration with AMP, NEOS, AZOA and Fractal Engine is in build. This is the planned flow, not a live one.
AMP brings the field in
Designed to bring sites, people and context into the shared operational picture.
Fractal Engine measures
Designed to measure outcomes against the research question.
NEOS records the decision
Designed to record who approved what, and why, in the agreement record.
AZOA settles the value
Designed to settle value with the people who did the work, under their consent.
